IL33 and endothelial dysfunction: An increase in IL-33 expression was observed in atherosclerotic plaques, and thrombin-induced interleukin-33 expression plays a role in endothelial dysfunction, stimulates vascular endothelial damage, is involved in regulating HASMC proliferation and migration, and promotes vascular wall remodeling.